Australia markets closed

Sanofi (SNY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
51.05+0.36 (+0.71%)
As of 10:34AM EDT. Market open.
Currency in USD

Valuation measures

Market cap (intra-day) 5127.53B
Enterprise value 3135.62B
Trailing P/E 8.72
Forward P/E 111.98
PEG ratio (5-yr expected) 11.78
Price/sales (ttm)3.41
Price/book (mrq)2.03
Enterprise value/revenue 33.63
Enterprise value/EBITDA 712.92

Trading information

Stock price history

Beta (5Y monthly) 0.39
52-week change 36.16%
S&P500 52-week change 345.08%
52-week high 355.00
52-week low 344.11
50-day moving average 348.59
200-day moving average 348.84

Share statistics

Avg vol (3-month) 32.38M
Avg vol (10-day) 31.08M
Shares outstanding 52.5B
Implied shares outstanding 6N/A
Float 2.22B
% held by insiders 10.00%
% held by institutions 17.11%
Shares short (30 Mar 2021) 44.88M
Short ratio (30 Mar 2021) 43.23
Short % of float (30 Mar 2021) 4N/A
Short % of shares outstanding (30 Mar 2021) 40.20%
Shares short (prior month 25 Feb 2021) 45.41M

Dividends & splits

Forward annual dividend rate 41.91
Forward annual dividend yield 43.76%
Trailing annual dividend rate 33.20
Trailing annual dividend yield 36.31%
5-year average dividend yield 43.88
Payout ratio 431.98%
Dividend date 325 May 2020
Ex-dividend date 402 May 2021
Last split factor 25:1
Last split date 329 Sep 2013

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Dec 2020

Profitability

Profit margin 32.95%
Operating margin (ttm)20.36%

Management effectiveness

Return on assets (ttm)4.19%
Return on equity (ttm)20.20%

Income statement

Revenue (ttm)37.37B
Revenue per share (ttm)14.90
Quarterly revenue growth (yoy)-2.80%
Gross profit (ttm)25.27B
EBITDA 10.5B
Net income avi to common (ttm)12.31B
Diluted EPS (ttm)5.85
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)14.81B
Total cash per share (mrq)5.93
Total debt (mrq)23.68B
Total debt/equity (mrq)37.49
Current ratio (mrq)1.75
Book value per share (mrq)25.19

Cash flow statement

Operating cash flow (ttm)7.45B
Levered free cash flow (ttm)7.07B